United States Financial Markets News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Oops... There was a problem with your request.
- Country "se" not found.
Search entities
Discover all 32,649 supported financial entities for United States financial markets here.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 506,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "aedc2863-597d-442c-b3a9-57e4f88b09e2",
"title": "Southern Company, EPRI Program To Accelerate Emerging Technologies",
"description": "ATLANTA, GA / ACCESS Newswire / May 31, 2025 / Southern Company and EPRI, a non-profit energy research and development organization, are launching a pilot progr",
"keywords": "GuruFocus, Article, News, ACCESSWIRE, NYSE:SO",
"snippet": "ATLANTA, GA / ACCESS Newswire / May 31, 2025 / Southern Company and EPRI, a non-profit energy research and development organization, are launching a pilot progr...",
"url": "https://www.gurufocus.com/news/2900015/southern-company-epri-program-to-accelerate-emerging-technologies",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-31T21:00:02.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "SO",
"name": "The Southern Company",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Utilities",
"match_score": 10.373745,
"sentiment_score": 0.91,
"highlights": [
{
"highlight": "About Southern Company\n\nSouthern Company[+245 characters]",
"sentiment": 0.91,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "f79b7ebc-0c58-4c00-9438-192faed2f27e",
"title": "EOG Resources (EOG) Expands Utica Shale Holdings with $5.6B Acquisition",
"description": "Key Highlights:\n EOG Resources has acquired Encino Acquisition Partners for $5.6 billion, enhancing its position in the Utica shale. Analysts forecast a p",
"keywords": "GuruFocus, Article, News, GuruFocus News, EOG",
"snippet": "Key Highlights:\n\nEOG Resources has acquired Encino Acquisition Partners for $5.6 billion, enhancing its position in the Utica shale.\n\nAnalysts forecast a potent...",
"url": "https://www.gurufocus.com/news/2900011/eog-resources-eog-expands-utica-shale-holdings-with-56b-acquisition",
"image_url": "https://static.gurufocus.com/logos/0C000007HH.png?20",
"language": "en",
"published_at": "2025-05-31T20:55:31.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "EOG",
"name": "EOG Resources, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Energy",
"match_score": 102.00462,
"sentiment_score": 0.180629,
"highlights": [
{
"highlight": "Key Highlights:\n\n<em>EOG</em> <em>Resour[+371 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>EOG</em> <em>Resources</em> (EOG) ha[+154 characters]",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts' Insights\n\nTaking i[+334 characters]",
"sentiment": -0.25,
"highlighted_in": "main_text"
},
{
"highlight": "For a comprehensive outlook on these pre[+313 characters]",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "Valuation Metrics and Future Projections[+271 characters]",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "For more detailed insights, refer to the[+65 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>EOG</em> <em>Resources</em> (EOG) Expands Utica Shale Holdings with $5.6B Acquisition",
"sentiment": 0.1027,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "bd1b61f5-367b-4fdc-ae43-4860e976c2a7",
"title": "Key deals this week: EOG Resources, VivoPower, Servotronics, Eli Lilly and more (CA:NASDAQ)",
"description": "Discover key industry acquisitions, including EOG Resources' $5.6B deal and Strathcona's $4.25B bid.",
"keywords": "",
"snippet": "Here's a list of key deals reported across sectors this week:\n\nStrathcona Resources (OTCPK:STHRF) said Friday it formally launched its offer to acquire MEG Ener...",
"url": "https://seekingalpha.com/news/4454030-key-deals-this-week-eog-resources-vivopower-servotronics-eli-lilly-and-more",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/876353660/image_876353660.jpg?io=getty-c-w750",
"language": "en",
"published_at": "2025-05-31T19:15:16.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "EOG",
"name": "EOG Resources, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Energy",
"match_score": 73.54867,
"sentiment_score": 0.1366,
"highlights": [
{
"highlight": "<em>EOG</em> <em>Resources</em> (<em>NYS[+36 characters]",
"sentiment": 0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Key deals this week: <em>EOG</em> <em>Resources</em>, VivoPower, Servotronics, Eli Lilly and more (CA:NASDAQ)",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "5d788960-3ec8-44a8-9024-e6a59ca16f70",
"title": "JPMorgan CEO Warns Rising Debt Could Impact U.S. Bond Market (JPM)",
"description": "CEO Jamie Dimon raises alarms over the federal debt's potential impact on the U.S. bond market. Analysts predict a modest 2.17% upside in JPMorgan Chase",
"keywords": "GuruFocus, Article, News, GuruFocus News, JPM",
"snippet": "CEO Jamie Dimon raises alarms over the federal debt's potential impact on the U.S. bond market.\n\nAnalysts predict a modest 2.17% upside in JPMorgan Chase stock ...",
"url": "https://www.gurufocus.com/news/2900010/jpmorgan-ceo-warns-rising-debt-could-impact-us-bond-market-jpm",
"image_url": "https://static.gurufocus.com/logos/0C00000BMT.png?20",
"language": "en",
"published_at": "2025-05-31T20:55:17.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "JPM",
"name": "JPMorgan Chase & Co.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 49.632133,
"sentiment_score": 0.098867,
"highlights": [
{
"highlight": "Analysts predict a modest 2.17% upside i[+164 characters]",
"sentiment": 0.0258,
"highlighted_in": "main_text"
},
{
"highlight": "Jamie Dimon, the esteemed CEO of <em>JPM[+282 characters]",
"sentiment": -0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts' Insights\n\nThe anal[+330 characters]",
"sentiment": 0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "For a deeper dive into the price forecas[+339 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Understanding GuruFocus Metrics\n\nAccordi[+227 characters]",
"sentiment": 0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "More comprehensive data is available on [+70 characters]",
"sentiment": 0.3102,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "11de2160-7aa9-4192-a34c-b89104f8d9b6",
"title": "Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting | ZLAB Stock News",
"description": "The Phase 3 PANOVA-3 trial shows TTFields therapy significantly improves overall survival in pancreatic cancer. TTFields therapy demonstrated a 2-month",
"keywords": "GuruFocus, Article, News, GuruFocus News, ZLAB",
"snippet": "The Phase 3 PANOVA-3 trial shows TTFields therapy significantly improves overall survival in pancreatic cancer.\n\nTTFields therapy demonstrated a 2-month increas...",
"url": "https://www.gurufocus.com/news/2900009/zai-lab-and-novocure-announce-results-from-the-phase-3-panova3-trial-of-tumor-treating-fields-ttfields-therapy-for-pancreatic-cancer-to-be-presented-at-2025-asco-annual-meeting-zlab-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000BBJG.png?20",
"language": "en",
"published_at": "2025-05-31T20:15:09.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "ZLAB",
"name": "Zai Lab Limited",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 58.19176,
"sentiment_score": -0.7196,
"highlights": [
{
"highlight": "<em>Zai</em> <em>Lab</em> <em>Limited</e[+325 characters]",
"sentiment": -0.6486,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Zai</em> <em>Lab</em> and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting | ZLAB Stock News",
"sentiment": -0.7906,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "727adca4-03df-461f-b2b6-d794c21bc248",
"title": "Regeneron Pharmaceuticals Inc (REGN) Announces Promising Phase 3 Trial Results for Libtayo in High-Risk CSCC | REGN stock news",
"description": "Summary Regeneron Pharmaceuticals Inc (REGN) has announced promising results from its Phase 3 C-POST trial, evaluating the PD-1 inhibitor Libtayo® (cemiplimab)",
"keywords": "GuruFocus, Article, News, GuruFocus News, REGN",
"snippet": "Summary\n\nRegeneron Pharmaceuticals Inc (REGN, Financial) has announced promising results from its Phase 3 C-POST trial, evaluating the PD-1 inhibitor Libtayo® ...",
"url": "https://www.gurufocus.com/news/2899945/regeneron-pharmaceuticals-inc-regn-announces-promising-phase-3-trial-results-for-libtayo-in-highrisk-cscc-regn-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-31T14:01:57.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "0R2M.L",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 103.0706,
"sentiment_score": 0.37095,
"highlights": [
{
"highlight": "Summary\n\n<em>Regeneron</em> <em>Pharmace[+241 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</em> <em>Inc</em> (REGN) Announces Promising Phase 3 Trial Results for Libtayo in High-Risk CSCC | REGN stock news",
"sentiment": 0.4019,
"highlighted_in": "title"
}
]
},
{
"symbol": "REGN",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 103.061874,
"sentiment_score": 0.37095,
"highlights": [
{
"highlight": "Summary\n\n<em>Regeneron</em> <em>Pharmace[+241 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</em> <em>Inc</em> (REGN) Announces Promising Phase 3 Trial Results for Libtayo in High-Risk CSCC | REGN stock news",
"sentiment": 0.4019,
"highlighted_in": "title"
}
]
},
{
"symbol": "REGN34.SA",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 103.05528,
"sentiment_score": 0.37095,
"highlights": [
{
"highlight": "Summary\n\n<em>Regeneron</em> <em>Pharmace[+241 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</em> <em>Inc</em> (REGN) Announces Promising Phase 3 Trial Results for Libtayo in High-Risk CSCC | REGN stock news",
"sentiment": 0.4019,
"highlighted_in": "title"
}
]
},
{
"symbol": "REGN.MX",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 103.05645,
"sentiment_score": 0.37095,
"highlights": [
{
"highlight": "Summary\n\n<em>Regeneron</em> <em>Pharmace[+241 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</em> <em>Inc</em> (REGN) Announces Promising Phase 3 Trial Results for Libtayo in High-Risk CSCC | REGN stock news",
"sentiment": 0.4019,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "397c2098-b811-44a8-9ba7-2a6966e5b96e",
"title": "Gilead Sciences Inc (GILD) Announces Promising Results for Trodelvy and Keytruda Combination in Breast Cancer Treatment | GILD stock news",
"description": "Summary Gilead Sciences Inc (GILD) has announced that its drug Trodelvy® (sacituzumab govitecan-hziy), when combined with Keytruda® (pembrolizumab), significa",
"keywords": "GuruFocus, Article, News, GuruFocus News, GILD",
"snippet": "Summary\n\nGilead Sciences Inc (GILD, Financial) has announced that its drug Trodelvy® (sacituzumab govitecan-hziy), when combined with Keytruda® (pembrolizumab...",
"url": "https://www.gurufocus.com/news/2899943/gilead-sciences-inc-gild-announces-promising-results-for-trodelvy-and-keytruda-combination-in-breast-cancer-treatment-gild-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-31T14:01:29.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "GILD",
"name": "Gilead Sciences, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 106.39114,
"sentiment_score": -0.56015,
"highlights": [
{
"highlight": "Summary\n\n<em>Gilead</em> <em>Sciences</e[+342 characters]",
"sentiment": -0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Gilead</em> <em>Sciences</em> <em>Inc</em> (GILD) Announces Promising Results for Trodelvy and Keytruda Combination in Breast Cancer Treatment | GILD stock news",
"sentiment": -0.4019,
"highlighted_in": "title"
}
]
},
{
"symbol": "GILDD.BA",
"name": "GILEAD SCIENCES",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 94.42236,
"sentiment_score": -0.56015,
"highlights": [
{
"highlight": "Summary\n\n<em>Gilead</em> <em>Sciences</e[+333 characters]",
"sentiment": -0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Gilead</em> <em>Sciences</em> Inc (GILD) Announces Promising Results for Trodelvy and Keytruda Combination in Breast Cancer Treatment | GILD stock news",
"sentiment": -0.4019,
"highlighted_in": "title"
}
]
},
{
"symbol": "GIS.DE",
"name": "Gilead Sciences, Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 106.37713,
"sentiment_score": -0.56015,
"highlights": [
{
"highlight": "Summary\n\n<em>Gilead</em> <em>Sciences</e[+342 characters]",
"sentiment": -0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Gilead</em> <em>Sciences</em> <em>Inc</em> (GILD) Announces Promising Results for Trodelvy and Keytruda Combination in Breast Cancer Treatment | GILD stock news",
"sentiment": -0.4019,
"highlighted_in": "title"
}
]
},
{
"symbol": "GILD.MX",
"name": "Gilead Sciences, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 106.36574,
"sentiment_score": -0.56015,
"highlights": [
{
"highlight": "Summary\n\n<em>Gilead</em> <em>Sciences</e[+342 characters]",
"sentiment": -0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Gilead</em> <em>Sciences</em> <em>Inc</em> (GILD) Announces Promising Results for Trodelvy and Keytruda Combination in Breast Cancer Treatment | GILD stock news",
"sentiment": -0.4019,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "7a204204-ec07-467a-84b4-9dde533d59d9",
"title": "Libtayo® (cemiplimab) Phase 3 Data in the Adjuvant Treatment of Post-Surgical High-Risk Cutaneous Squamous Cell Carcinoma (CSCC) Have Potential to Be Practice-Changing | REGN Stock News",
"description": "Libtayo® (cemiplimab) Phase 3 trial shows 68% reduction in disease recurrence or death risk for high-risk CSCC after surgery. Trial reveals 87% disease",
"keywords": "GuruFocus, Article, News, GuruFocus News, REGN",
"snippet": "Libtayo® (cemiplimab) Phase 3 trial shows 68% reduction in disease recurrence or death risk for high-risk CSCC after surgery.\n\nTrial reveals 87% disease-free s...",
"url": "https://www.gurufocus.com/news/2899915/libtayo-cemiplimab-phase-3-data-in-the-adjuvant-treatment-of-postsurgical-highrisk-cutaneous-squamous-cell-carcinoma-cscc-have-potential-to-be-practicechanging-regn-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000008R4.png?20",
"language": "en",
"published_at": "2025-05-31T13:15:27.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "REGN",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 40.920944,
"sentiment_score": 0.2023,
"highlights": [
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</[+231 characters]",
"sentiment": 0.2023,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "REGN.MX",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 40.919144,
"sentiment_score": 0.2023,
"highlights": [
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</[+231 characters]",
"sentiment": 0.2023,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0R2M.L",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 40.91459,
"sentiment_score": 0.2023,
"highlights": [
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</[+231 characters]",
"sentiment": 0.2023,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "REGN34.SA",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 40.910954,
"sentiment_score": 0.2023,
"highlights": [
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</[+231 characters]",
"sentiment": 0.2023,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "19597493-086a-4e7b-a5f4-c2a27046ea8e",
"title": "ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Bitfarms Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action -- BITF",
"description": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bitfarms Ltd. ( BITF)",
"keywords": "GuruFocus, Article, News, Marketwired, BITF",
"snippet": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) --\n\nWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bitfarms Ltd. ( BITF) be...",
"url": "https://www.gurufocus.com/news/2900006/rosen-global-investor-counsel-encourages-bitfarms-ltd-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-bitf",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-31T20:00:02.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "BITF",
"name": "Bitfarms Ltd.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 121.291916,
"sentiment_score": 0.6331,
"highlights": [
{
"highlight": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) [+291 characters]",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "ROSEN, GLOBAL INVESTOR COUNSEL, Encourages <em>Bitfarms</em> <em>Ltd</em>. Investors to Secure Counsel Before Important Deadline in Securities Class Action -- <em>BITF</em>",
"sentiment": 0.8074,
"highlighted_in": "title"
}
]
},
{
"symbol": "BFARF",
"name": "Bitfarms Ltd.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 90.534485,
"sentiment_score": 0.6331,
"highlights": [
{
"highlight": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) [+282 characters]",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "ROSEN, GLOBAL INVESTOR COUNSEL, Encourages <em>Bitfarms</em> <em>Ltd</em>. Investors to Secure Counsel Before Important Deadline in Securities Class Action -- BITF",
"sentiment": 0.8074,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "a7aa2fab-c747-4530-aeff-a6b394f0f154",
"title": "ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Avis Budget Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAR",
"description": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Avis Budget Group, In",
"keywords": "GuruFocus, Article, News, Marketwired, CAR",
"snippet": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) --\n\nWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Avis Budget Group, Inc. ...",
"url": "https://www.gurufocus.com/news/2900000/rosen-global-investor-counsel-encourages-avis-budget-group-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-car",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-31T19:00:02.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "0HK4.L",
"name": "Avis Budget Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 100.11216,
"sentiment_score": 0.0944,
"highlights": [
{
"highlight": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) [+314 characters]",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "SO WHAT: If you purchased <em>Avis</em> [+293 characters]",
"sentiment": 0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "DETAILS OF THE CASE: According to the la[+330 characters]",
"sentiment": -0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "of Avis Budget’s vehicles in the Ameri[+337 characters]",
"sentiment": -0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "To join the <em>Avis</em> <em>Budget</em[+300 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "ROSEN, GLOBAL INVESTOR COUNSEL, Encourages <em>Avis</em> <em>Budget</em> <em>Group</em>, <em>Inc</em>. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAR",
"sentiment": 0.8074,
"highlighted_in": "title"
}
]
},
{
"symbol": "CAR",
"name": "Avis Budget Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 100.11156,
"sentiment_score": 0.0944,
"highlights": [
{
"highlight": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) [+314 characters]",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "SO WHAT: If you purchased <em>Avis</em> [+293 characters]",
"sentiment": 0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "DETAILS OF THE CASE: According to the la[+330 characters]",
"sentiment": -0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "of Avis Budget’s vehicles in the Ameri[+337 characters]",
"sentiment": -0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "To join the <em>Avis</em> <em>Budget</em[+300 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "ROSEN, GLOBAL INVESTOR COUNSEL, Encourages <em>Avis</em> <em>Budget</em> <em>Group</em>, <em>Inc</em>. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAR",
"sentiment": 0.8074,
"highlighted_in": "title"
}
]
},
{
"symbol": "CAR.BA",
"name": "Avis Budget Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "Industrials",
"match_score": 100.11064,
"sentiment_score": 0.0944,
"highlights": [
{
"highlight": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) [+314 characters]",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "SO WHAT: If you purchased <em>Avis</em> [+293 characters]",
"sentiment": 0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "DETAILS OF THE CASE: According to the la[+330 characters]",
"sentiment": -0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "of Avis Budget’s vehicles in the Ameri[+337 characters]",
"sentiment": -0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "To join the <em>Avis</em> <em>Budget</em[+300 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "ROSEN, GLOBAL INVESTOR COUNSEL, Encourages <em>Avis</em> <em>Budget</em> <em>Group</em>, <em>Inc</em>. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAR",
"sentiment": 0.8074,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "e01f41f1-fce6-464d-af11-159eb6213f54",
"title": "DNUT INVESTOR NOTICE: Krispy Kreme, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit",
"description": "PR NewswireSAN DIEGO, May 31, 2025\n\n\n\nSAN DIEGO, May 31, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that The Krispy Kreme class action la",
"keywords": "GuruFocus, Article, News, PRNewswire, NAS:DNUT",
"snippet": "SAN DIEGO, May 31, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that The Krispy Kreme class action lawsuit – captioned Cameron v. Krispy Kr...",
"url": "https://www.gurufocus.com/news/2899997/dnut-investor-notice-krispy-kreme-inc-investors-with-substantial-losses-have-opportunity-to-lead-investor-class-action-lawsuit",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-31T18:00:02.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "MCD.SN",
"name": "McDonald's Corporation",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 24.593527,
"sentiment_score": -0.3959,
"highlights": [
{
"highlight": "On October 26, 2022, Krispy Kreme commen[+324 characters]",
"sentiment": 0.0258,
"highlighted_in": "main_text"
},
{
"highlight": "The Krispy Kreme class action lawsuit al[+332 characters]",
"sentiment": -0.836,
"highlighted_in": "main_text"
},
{
"highlight": "per door per week; (iii) the partnership[+242 characters]",
"sentiment": -0.216,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, Krispy Kreme announced tha[+251 characters]",
"sentiment": -0.5574,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MCD",
"name": "McDonald's Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 24.593672,
"sentiment_score": -0.3959,
"highlights": [
{
"highlight": "On October 26, 2022, Krispy Kreme commen[+324 characters]",
"sentiment": 0.0258,
"highlighted_in": "main_text"
},
{
"highlight": "The Krispy Kreme class action lawsuit al[+332 characters]",
"sentiment": -0.836,
"highlighted_in": "main_text"
},
{
"highlight": "per door per week; (iii) the partnership[+242 characters]",
"sentiment": -0.216,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, Krispy Kreme announced tha[+251 characters]",
"sentiment": -0.5574,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MDO.DE",
"name": "McDonald's Corporation",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 24.593746,
"sentiment_score": -0.3959,
"highlights": [
{
"highlight": "On October 26, 2022, Krispy Kreme commen[+324 characters]",
"sentiment": 0.0258,
"highlighted_in": "main_text"
},
{
"highlight": "The Krispy Kreme class action lawsuit al[+332 characters]",
"sentiment": -0.836,
"highlighted_in": "main_text"
},
{
"highlight": "per door per week; (iii) the partnership[+242 characters]",
"sentiment": -0.216,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, Krispy Kreme announced tha[+251 characters]",
"sentiment": -0.5574,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MCD.MX",
"name": "McDonald's Corporation",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 24.593836,
"sentiment_score": -0.3959,
"highlights": [
{
"highlight": "On October 26, 2022, Krispy Kreme commen[+324 characters]",
"sentiment": 0.0258,
"highlighted_in": "main_text"
},
{
"highlight": "The Krispy Kreme class action lawsuit al[+332 characters]",
"sentiment": -0.836,
"highlighted_in": "main_text"
},
{
"highlight": "per door per week; (iii) the partnership[+242 characters]",
"sentiment": -0.216,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, Krispy Kreme announced tha[+251 characters]",
"sentiment": -0.5574,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MCDC34.SA",
"name": "McDonald's Corporation",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 24.59399,
"sentiment_score": -0.3959,
"highlights": [
{
"highlight": "On October 26, 2022, Krispy Kreme commen[+324 characters]",
"sentiment": 0.0258,
"highlighted_in": "main_text"
},
{
"highlight": "The Krispy Kreme class action lawsuit al[+332 characters]",
"sentiment": -0.836,
"highlighted_in": "main_text"
},
{
"highlight": "per door per week; (iii) the partnership[+242 characters]",
"sentiment": -0.216,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, Krispy Kreme announced tha[+251 characters]",
"sentiment": -0.5574,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "85ac038a-3fbb-4e27-9a11-435ef6a6ce5e",
"title": "Google (GOOG) Faces Potential Antitrust Actions Amidst AI Expansion",
"description": "Quick Summary:\n U.S. District Judge Amit Mehta explores measures to address Google's (GOOG) dominance in the search market amid evolving AI dynamics. Anal",
"keywords": "GuruFocus, Article, News, GuruFocus News, GOOG",
"snippet": "Quick Summary:\n\nU.S. District Judge Amit Mehta explores measures to address Google's (GOOG, Financial) dominance in the search market amid evolving AI dynamics....",
"url": "https://www.gurufocus.com/news/2900005/google-goog-faces-potential-antitrust-actions-amidst-ai-expansion",
"image_url": "https://static.gurufocus.com/logos/0C000007XQ.png?20",
"language": "en",
"published_at": "2025-05-31T19:56:03.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "GOOG",
"name": "Alphabet Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 18.184662,
"sentiment_score": 0.449475,
"highlights": [
{
"highlight": "Analysts forecast an average one-year pr[+238 characters]",
"sentiment": 0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "For more insights, visit the <em>Alphabe[+308 characters]",
"sentiment": 0.886,
"highlighted_in": "main_text"
},
{
"highlight": "Furthermore, GuruFocus metrics provide a[+188 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "To explore further data, visit the <em>A[+46 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GOOGL",
"name": "Alphabet Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 29.87424,
"sentiment_score": 0.46978,
"highlights": [
{
"highlight": "Analysts forecast an average one-year pr[+238 characters]",
"sentiment": 0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "Analyst Price Targets and Market Predict[+254 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "For more insights, visit the <em>Alphabe[+308 characters]",
"sentiment": 0.886,
"highlighted_in": "main_text"
},
{
"highlight": "This places <em>Alphabet</em> in the \"Ou[+309 characters]",
"sentiment": 0.891,
"highlighted_in": "main_text"
},
{
"highlight": "To explore further data, visit the <em>A[+46 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "a139eac3-4db4-4c1c-9e10-76726c689562",
"title": "Google plans to challenge antitrust ruling on search monopoly remedies (GOOG:NASDAQ)",
"description": "Google plans to challenge antitrust ruling on search monopoly remedies",
"keywords": "",
"snippet": "Google (NASDAQ:GOOG) (GOOGL) announced its intention to appeal a federal judge's ruling in an ongoing antitrust case focused on its dominance in online search a...",
"url": "https://seekingalpha.com/news/4454050-google-plans-to-challenge-antitrust-ruling-on-search-monopoly-remedies",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1337403704/image_1337403704.jpg?io=getty-c-w750",
"language": "en",
"published_at": "2025-05-31T19:51:10.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "GOOG",
"name": "Alphabet Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 18.322441,
"sentiment_score": 0.2263,
"highlights": [
{
"highlight": "Google (<em>NASDAQ:GOOG</em>) (GOOGL) an[+241 characters]",
"sentiment": 0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GOOGL",
"name": "Alphabet Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 24.159777,
"sentiment_score": 0.2263,
"highlights": [
{
"highlight": "Google (NASDAQ:GOOG) (<em>GOOGL</em>) an[+250 characters]",
"sentiment": 0.2263,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "550f6e82-163a-46b5-893e-3d253fa21f53",
"title": "Hims & Hers Health: Peptide And Short Squeeze Are Coming! (NYSE:HIMS)",
"description": "Hims & Hers is evolving beyond its original focus, aggressively expanding into peptides and GLP-1. Read why I reiterate my Buy rating on HIMS stock.",
"keywords": "",
"snippet": "Hims & Hers (NYSE: HIMS ) is the company of the future. I've already written about HIMS twice on Seeking Alpha ( see here and here ) and over 50 posts on a pers...",
"url": "https://seekingalpha.com/article/4791449-hims-and-hers-peptide-plus-short-squeeze-are-coming",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1430043609/image_1430043609.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2025-05-31T19:37:48.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "HIMS",
"name": "Hims & Hers Health, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Defensive",
"match_score": 157.74574,
"sentiment_score": 0.26335,
"highlights": [
{
"highlight": "Hims & Hers (<em>NYSE</em>: <em>HIMS</em[+257 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Hims</em> & <em>Hers</em> <em>Health</em>: Peptide And Short Squeeze Are Coming! (<em>NYSE:HIMS</em>)",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "2c7cfa0d-01bd-45e6-9417-2a6d93a6ac55",
"title": "Hims & Hers Health is laying off staff (HIMS:NYSE)",
"description": "Hims & Hers Health (HIMS) lays off 4% of its workforce as the company adjusted its strategy amid FDA scrutiny on copycat versions of weight loss drugs. Read more here.",
"keywords": "",
"snippet": "Hims & Hers Health (NYSE:HIMS) is laying off about 4% of its employees as the telehealth firm adapts its strategy in a market where the sale of cheaper compound...",
"url": "https://seekingalpha.com/news/4454034-hims-hers-health-is-laying-off-staff",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2164034397/image_2164034397.jpg?io=getty-c-w750",
"language": "en",
"published_at": "2025-05-31T12:18:46.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "HIMS",
"name": "Hims & Hers Health, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Defensive",
"match_score": 119.218445,
"sentiment_score": -0.08895,
"highlights": [
{
"highlight": "<em>Hims</em> & <em>Hers</em> <em>Health[+233 characters]",
"sentiment": -0.1779,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Hims</em> & <em>Hers</em> <em>Health</em> is laying off staff (HIMS:NYSE)",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "ae4d7707-22d5-443c-8a91-719689174812",
"title": "Gary Black Questions Tesla’s Sky-High Forward P/E Ratio: ‘Long-Term Growth Rate Needed To Justify a 180X P/E Would Cause Tsla Market Cap To Be Bigger' - Microsoft (NASDAQ:MSFT), Apple (NASDAQ:AAPL)",
"description": "Gary Black, Future Fund LLC's managing director and a prominent market analyst, has expressed concerns about Tesla Inc.'s high forward price-to-earnings (P/E) ratio.",
"keywords": "",
"snippet": "Gary Black, Future Fund LLC’s managing director and a prominent market analyst, has expressed concerns about Tesla Inc.’s TSLA high forward price-to-earning...",
"url": "https://www.benzinga.com/markets/guidance/25/05/45710828/gary-black-questions-teslas-sky-high-forward-p-e-ratio-long-term-growth-rate-needed-to-justify-a",
"image_url": "https://cdn.benzinga.com/files/images/story/2025/05/31/San-Jose--California-Us---December-21--2.jpeg?width=1200&height=800&fit=crop",
"language": "en",
"published_at": "2025-05-31T19:25:35.000000Z",
"source": "benzinga.com",
"relevance_score": null,
"entities": [
{
"symbol": "AAPL",
"name": "Apple Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 35.343716,
"sentiment_score": 0.2038,
"highlights": [
{
"highlight": "Black argued that the long-term growth r[+168 characters]",
"sentiment": 0.0258,
"highlighted_in": "main_text"
},
{
"highlight": "Gary Black Questions Tesla’s Sky-High Forward P/E Ratio: ‘Long-Term Growth Rate Needed To Justify a 180X P/E Would Cause Tsla Market Cap To Be Bigger' - Microsoft (NASDAQ:MSFT), <em>Apple</em> (<em>NASDAQ:AAPL</em>)",
"sentiment": 0.3818,
"highlighted_in": "title"
}
]
},
{
"symbol": "MSFT",
"name": "Microsoft Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 29.724821,
"sentiment_score": 0.3389,
"highlights": [
{
"highlight": "AAPL and <em>Microsoft</em> Corp. MSFT, [+291 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Gary Black Questions Tesla’s Sky-High Forward P/E Ratio: ‘Long-Term Growth Rate Needed To Justify a 180X P/E Would Cause Tsla Market Cap To Be Bigger' - <em>Microsoft</em> (<em>NASDAQ:MSFT</em>), Apple (NASDAQ:AAPL)",
"sentiment": 0.3818,
"highlighted_in": "title"
}
]
},
{
"symbol": "TSLA",
"name": "Tesla, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 17.923477,
"sentiment_score": -0.166867,
"highlights": [
{
"highlight": "Gary Black, Future Fund LLC’s managing[+209 characters]",
"sentiment": 0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "Also Read: Gary Black Says Tesla’s Rob[+186 characters]",
"sentiment": -0.7269,
"highlighted_in": "main_text"
},
{
"highlight": "While Black clarified that he doesn’t [+268 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "704a0ab9-8914-421f-9540-b92dd4ea7dbc",
"title": "A-Mark Precious Metals: Follow The Cash Flow (NASDAQ:AMRK)",
"description": "While A-Mark remains highly levered, they remain well capitalized thanks to the liquidity of their inventory. Read why I rate AMRK stock a Buy now.",
"keywords": "",
"snippet": "My articles are written for the purpose of keeping a public track record of successful investments ideas. My articles are high-level and succinct and not intend...",
"url": "https://seekingalpha.com/article/4791448-a-mark-precious-metals-follow-the-cash-flow",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/495874198/image_495874198.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2025-05-31T19:24:45.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "AMRK",
"name": "A-Mark Precious Metals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 138.95981,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>A</em>-<em>Mark</em> <em>Precious</em> <em>Metals</em>: Follow The Cash Flow (<em>NASDAQ:AMRK</em>)",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "us",
"total_documents": 767,
"sentiment_avg": 0.29180824599821925
}
]
}
Other details
Entity count
- 32,649